Dr. Michael Edwin Confer, MD

Dr. Confer practices at Oklahoma Proton Center in Oklahoma City, Oklahoma.

Dr. Confer's NPI, 1336346337, was assigned on July 2, 2007. Dr. Confer graduated from OU College of Medicine in 2007. Dr. Confer's Oklahoma license number on file is 25799.

Dr. Confer's primary practice is Oklahoma Proton Center, at 5901 W Memorial Rd, Oklahoma City, OK 73142 in Oklahoma County. The practice phone is (918) 798-9160.

Dr. Confer's primary practice is Oklahoma Proton Center in Oklahoma City, Oklahoma. Dr. Confer is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Confer to 2 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Confer practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Confer's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Confer is board certified in radiation oncology by the American Board of Radiology. Dr. Confer has a license on file in Oklahoma.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation and lymphoma radiation among the conditions Dr. Confer treats.

CMS data shows 1,506 Medicare services from Dr. Confer across 16 procedure codes in 2024, for 267 Medicare patients. Medicare paid $108,861 for them.

CMS counts 267 Medicare patients who saw Dr. Confer in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Confer's median patient age at 73, with 51% women.

In 2024, Dr. Confer wrote 101 Medicare Part D claims for 45 patients. 92% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $514 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Confer for performance year 2024, reported as part of a group. Dr. Confer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Confer, published from 2014 to 2020. Dr. Confer's most frequent co-authors are Terence Spencer Herman, MD, Chance Lee Matthiesen, MD and Abeer N. Arain, MD, MPH.

CMS Open Payments shows 85 general payments to Dr. Confer from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novocure Inc. paid the most, $371.

Dr. Confer graduated from OU College of Medicine in 2007.

Dr. Confer is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.